Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
68
CUK Quote, Financials, Valuation and Earnings
Last price:
$24.32
Seasonality move
:
-0.4%
Day range:
$23.16 - $24.64
52-week range:
$12.50 - $24.66
Dividend yield:
0%
P/E ratio:
17.50x
P/S ratio:
1.30x
P/B ratio:
3.44x
Volume:
3.5M
Avg. volume:
1.4M
1-year change:
47.13%
Market cap:
$31.8B
Revenue:
$25B
EPS (TTM):
$1.39
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.6B | $1.9B | $12.2B | $21.6B | $25B | |
| Revenue Growth (YoY) | -73.14% | -65.89% | 537.79% | 77.44% | 15.88% | |
| Cost of Revenues | $10.5B | $6.9B | $14B | $16.7B | $18.2B | |
| Gross Profit | -$4.9B | -$5B | -$1.9B | $4.9B | $6.8B | |
| Gross Profit Margin | -87.45% | -260.95% | -15.31% | 22.72% | 27.28% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $1.9B | $2.5B | $3B | $3.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.9B | $1.9B | $2.5B | $3B | $3.3B | |
| Operating Income | -$6.8B | -$6.9B | -$4.4B | $2B | $3.6B | |
| Net Interest Expenses | $877M | $1.6B | $1.5B | $1.8B | $1.7B | |
| EBT. Incl. Unusual Items | -$10.3B | -$9.5B | -$6.1B | -$62M | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$17M | -$21M | $14M | $13M | -$1M | |
| Net Income to Company | -$10.2B | -$9.5B | -$6.1B | -$74M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.2B | -$9.5B | -$6.1B | -$74M | $1.9B | |
| Basic EPS (Cont. Ops) | -$13.20 | -$8.46 | -$5.16 | -$0.06 | $1.50 | |
| Diluted EPS (Cont. Ops) | -$13.20 | -$8.46 | -$5.16 | -$0.06 | $1.44 | |
| Weighted Average Basic Share | $775M | $1.1B | $1.2B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $775M | $1.1B | $1.2B | $1.3B | $1.4B | |
| EBITDA | -$7.1B | -$5.7B | -$2.2B | $4.4B | $3.7B | |
| EBIT | -$9.4B | -$7.9B | -$4.5B | $2B | $3.7B | |
| Revenue (Reported) | $5.6B | $1.9B | $12.2B | $21.6B | $25B | |
| Operating Income (Reported) | -$6.8B | -$6.9B | -$4.4B | $2B | $3.6B | |
| Operating Income (Adjusted) | -$9.4B | -$7.9B | -$4.5B | $2B | $3.7B | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $33M | $1.3B | $3.8B | $5.4B | $5.9B | |
| Revenue Growth (YoY) | -99.31% | 3800% | 198.29% | 40.56% | 10.05% | |
| Cost of Revenues | $1.2B | $2.4B | $4.2B | $4.2B | $4.5B | |
| Gross Profit | -$1.2B | -$1.1B | -$395M | $1.2B | $1.4B | |
| Gross Profit Margin | -3639.39% | -84.46% | -10.29% | 21.7% | 24.37% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $443M | $580M | $741M | $788M | $886M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $443M | $580M | $741M | $788M | $886M | |
| Operating Income | -$1.6B | -$1.7B | -$1.1B | $383M | $561M | |
| Net Interest Expenses | $345M | $346M | $408M | $416M | $387M | |
| EBT. Incl. Unusual Items | -$2.2B | -$2.6B | -$1.6B | -$39M | $290M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$15M | -$4M | -$3M | $10M | -$13M | |
| Net Income to Company | -$2.2B | -$2.6B | -$1.6B | -$48M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$2.2B | -$2.6B | -$1.6B | -$48M | $303M | |
| Basic EPS (Cont. Ops) | -$2.17 | -$2.32 | -$1.27 | -$0.04 | $0.23 | |
| Diluted EPS (Cont. Ops) | -$2.17 | -$2.32 | -$1.27 | -$0.04 | $0.23 | |
| Weighted Average Basic Share | $919M | $1.1B | $1.3B | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $919M | $1.1B | $1.3B | $1.3B | $1.4B | |
| EBITDA | -$1.3B | -$1.7B | -$586M | $1B | $693M | |
| EBIT | -$1.9B | -$2.3B | -$1.2B | $427M | $693M | |
| Revenue (Reported) | $33M | $1.3B | $3.8B | $5.4B | $5.9B | |
| Operating Income (Reported) | -$1.6B | -$1.7B | -$1.1B | $383M | $561M | |
| Operating Income (Adjusted) | -$1.9B | -$2.3B | -$1.2B | $427M | $693M | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.6B | $1.9B | $12.2B | $21.6B | $25B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.5B | $6.9B | $14B | $16.7B | $18.2B | |
| Gross Profit | -$4.9B | -$5B | -$1.9B | $4.9B | $6.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $1.9B | $2.5B | $2.9B | $3.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.9B | $1.9B | $2.5B | $2.9B | $3.3B | |
| Operating Income | -$6.8B | -$6.9B | -$4.4B | $2B | $3.6B | |
| Net Interest Expenses | $878M | $1.6B | $1.5B | $1.8B | $1.7B | |
| EBT. Incl. Unusual Items | -$10.3B | -$9.5B | -$6.1B | -$62M | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$17M | -$21M | $14M | $13M | -- | |
| Net Income to Company | -$10.2B | -$9.5B | -$6.1B | -$74M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.2B | -$9.5B | -$6.1B | -$74M | $1.9B | |
| Basic EPS (Cont. Ops) | -$13.07 | -$8.45 | -$5.19 | -$0.06 | $1.50 | |
| Diluted EPS (Cont. Ops) | -$13.07 | -$8.45 | -$5.19 | -$0.12 | $1.39 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$7.1B | -$5.7B | -$2.2B | $4.4B | $5.6B | |
| EBIT | -$9.4B | -$7.9B | -$4.5B | $2B | $3.7B | |
| Revenue (Reported) | $5.6B | $1.9B | $12.2B | $21.6B | $25B | |
| Operating Income (Reported) | -$6.8B | -$6.9B | -$4.4B | $2B | $3.6B | |
| Operating Income (Adjusted) | -$9.4B | -$7.9B | -$4.5B | $2B | $3.7B | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.6B | $1.9B | $12.2B | $21.6B | $25B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $10.5B | $6.9B | $14B | $16.7B | $18.2B | |
| Gross Profit | -$4.9B | -$5B | -$1.9B | $4.9B | $6.8B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.9B | $1.9B | $2.5B | $2.9B | $3.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.9B | $1.9B | $2.5B | $2.9B | $3.3B | |
| Operating Income | -$6.8B | -$6.9B | -$4.4B | $2B | $3.6B | |
| Net Interest Expenses | $878M | $1.6B | $1.5B | $1.8B | $1.7B | |
| EBT. Incl. Unusual Items | -$10.3B | -$9.5B | -$6.1B | -$62M | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$17M | -$21M | $14M | $13M | -- | |
| Net Income to Company | -$10.2B | -$9.5B | -$6.1B | -$74M | $1.6B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$10.2B | -$9.5B | -$6.1B | -$74M | $1.9B | |
| Basic EPS (Cont. Ops) | -$13.07 | -$8.45 | -$5.19 | -$0.06 | $1.50 | |
| Diluted EPS (Cont. Ops) | -$13.07 | -$8.45 | -$5.19 | -$0.12 | $1.39 | |
| Weighted Average Basic Share | $3.1B | $4.5B | $4.7B | $5B | $5.1B | |
| Weighted Average Diluted Share | $3.1B | $4.5B | $4.7B | $5.2B | $5.3B | |
| EBITDA | -$7.1B | -$5.7B | -$2.2B | $4.4B | $5.6B | |
| EBIT | -$9.4B | -$7.9B | -$4.5B | $2B | $3.7B | |
| Revenue (Reported) | $5.6B | $1.9B | $12.2B | $21.6B | $25B | |
| Operating Income (Reported) | -$6.8B | -$6.9B | -$4.4B | $2B | $3.6B | |
| Operating Income (Adjusted) | -$9.4B | -$7.9B | -$4.5B | $2B | $3.7B | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.5B | $8.9B | $4B | $2.4B | $1.2B | |
| Short Term Investments | -- | $200M | -- | -- | -- | |
| Accounts Receivable, Net | $273M | $246M | $395M | $556M | $590M | |
| Inventory | $335M | $356M | $428M | $528M | $507M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $442M | $378M | $652M | $1.8B | $1.1B | |
| Total Current Assets | $10.6B | $10.1B | $7.5B | $5.3B | $3.4B | |
| Property Plant And Equipment | $39.4B | $39.4B | $40B | $41.4B | $43.2B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $807M | $579M | $579M | $579M | $579M | |
| Other Intangibles | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Other Long-Term Assets | $1.6B | $2B | $2.5B | $725M | $775M | |
| Total Assets | $53.6B | $53.3B | $51.7B | $49.1B | $49.1B | |
| Accounts Payable | $624M | $797M | $1.1B | $1.2B | $1.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $151M | $142M | $146M | $149M | $163M | |
| Other Current Liabilities | $1M | -$1M | -- | -- | -- | |
| Total Current Liabilities | $8.7B | $10.4B | $10.6B | $11.5B | $11.6B | |
| Long-Term Debt | $22.1B | $28.5B | $32B | $28.5B | $25.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33B | $41.2B | $44.6B | $42.2B | $39.8B | |
| Common Stock | $372M | $372M | $373M | $373M | $374M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $20.6B | $12.1B | $7.1B | $6.9B | $9.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $20.6B | $12.1B | $7.1B | $6.9B | $9.3B | |
| Total Liabilities and Equity | $53.6B | $53.3B | $51.7B | $49.1B | $49.1B | |
| Cash and Short Terms | $9.5B | $9.1B | $4B | $2.4B | $1.2B | |
| Total Debt | $27B | $33.2B | $34.5B | $30.6B | $27.5B | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $9.5B | $8.9B | $4B | $2.4B | $1.2B | |
| Short Term Investments | -- | $200M | -- | -- | -- | |
| Accounts Receivable, Net | $273M | $246M | $395M | $556M | $590M | |
| Inventory | $335M | $356M | $428M | $528M | $507M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $442M | $378M | $652M | $1.8B | $1.1B | |
| Total Current Assets | $10.6B | $10.1B | $7.5B | $5.3B | $3.4B | |
| Property Plant And Equipment | $39.4B | $39.4B | $40B | $41.4B | $43.2B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $807M | $579M | $579M | $579M | $579M | |
| Other Intangibles | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | |
| Other Long-Term Assets | $1.6B | $2B | $2.5B | $725M | $775M | |
| Total Assets | $53.6B | $53.3B | $51.7B | $49.1B | $49.1B | |
| Accounts Payable | $624M | $797M | $1.1B | $1.2B | $1.1B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $151M | $142M | $146M | $149M | $163M | |
| Other Current Liabilities | $1M | -$1M | -- | -- | -- | |
| Total Current Liabilities | $8.7B | $10.4B | $10.6B | $11.5B | $11.6B | |
| Long-Term Debt | $22.1B | $28.5B | $32B | $28.5B | $25.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33B | $41.2B | $44.6B | $42.2B | $39.8B | |
| Common Stock | $372M | $372M | $373M | $373M | $374M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $20.6B | $12.1B | $7.1B | $6.9B | $9.3B | |
| Total Liabilities and Equity | $53.6B | $53.3B | $51.7B | $49.1B | $49.1B | |
| Cash and Short Terms | $9.5B | $9.1B | $4B | $2.4B | $1.2B | |
| Total Debt | $27B | $33.2B | $34.5B | $30.6B | $27.5B | |
| Period Ending | 2019-11-30 | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3B | -$10.2B | -$9.5B | -$6.1B | -$74M | |
| Depreciation & Amoritzation | $2.2B | $2.2B | $2.2B | $2.3B | $2.4B | |
| Stock-Based Compensation | $46M | $105M | $121M | $101M | $53M | |
| Change in Accounts Receivable | -$114M | $125M | -$7M | -$171M | -$180M | |
| Change in Inventories | $79M | $77M | -$63M | -$95M | -$85M | |
| Cash From Operations | $5.5B | -$6.3B | -$4.1B | -$1.7B | $4.3B | |
| Capital Expenditures | $5.4B | $3.6B | $3.6B | $4.9B | $3.3B | |
| Cash Acquisitions | -- | -$81M | -$90M | -$1M | -- | |
| Cash From Investing | -$5.3B | -$3.2B | -$3.5B | -$4.8B | -$2.8B | |
| Dividends Paid (Ex Special Dividend) | -$1.4B | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.7B | $15B | $13B | $7.2B | $3B | |
| Long-Term Debt Repaid | -$1.7B | -$1.6B | -$6.2B | -$4.7B | -$7.9B | |
| Repurchase of Common Stock | -$603M | -$12M | -- | -- | -- | |
| Other Financing Activities | -$1M | $1M | -$552M | -$2M | -$66M | |
| Cash From Financing | -$655M | $18.7B | $6.9B | $3.6B | -$5.1B | |
| Beginning Cash (CF) | $996M | $530M | $9.7B | $9B | $6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$457M | $9.1B | -$703M | -$2.9B | -$3.6B | |
| Ending Cash (CF) | $530M | $9.7B | $9B | $6B | $2.4B | |
| Levered Free Cash Flow | $46M | -$9.9B | -$7.7B | -$6.6B | $997M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$10.2B | -$9.5B | -$6.1B | -$74M | -- | |
| Depreciation & Amoritzation | $2.2B | $2.2B | $2.3B | $2.4B | -- | |
| Stock-Based Compensation | $105M | $121M | $101M | $53M | $47M | |
| Change in Accounts Receivable | $125M | -$7M | -$171M | -$180M | -- | |
| Change in Inventories | $77M | -$63M | -$95M | -$85M | -- | |
| Cash From Operations | -$6.3B | -$4.1B | -$1.7B | $4.3B | -- | |
| Capital Expenditures | $3.6B | $3.6B | $4.9B | $3.3B | $4B | |
| Cash Acquisitions | -$81M | -$90M | -- | -- | -- | |
| Cash From Investing | -$3.2B | -$3.5B | -$4.8B | -$2.8B | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $15B | $13B | $7.2B | $3B | -- | |
| Long-Term Debt Repaid | -$1.6B | -$6.2B | -$4.7B | -$7.9B | -- | |
| Repurchase of Common Stock | -$12M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$2M | -- | -- | |
| Cash From Financing | $18.7B | $6.9B | $3.6B | -$5.1B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.1B | -$703M | -$2.9B | -$3.6B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$9.9B | -$7.7B | -$6.6B | $997M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$8B | -$6.9B | -$4.5B | -$26M | $1.6B | |
| Depreciation & Amoritzation | $1.7B | $1.7B | $1.7B | $1.8B | $1.9B | |
| Stock-Based Compensation | $52M | $95M | $79M | $43M | $47M | |
| Change in Accounts Receivable | $25M | -$37M | -$134M | -$99M | -$72M | |
| Change in Inventories | $71M | -$19M | -$87M | -$43M | $33M | |
| Cash From Operations | -$4.6B | -$3.7B | -$1.6B | $3.4B | $5B | |
| Capital Expenditures | $1.9B | $3.1B | $3.8B | $2.6B | $4B | |
| Cash Acquisitions | -$81M | -$90M | -- | -- | -- | |
| Cash From Investing | -$1.5B | -$3.5B | -$3.5B | -$2.3B | -$4B | |
| Dividends Paid (Ex Special Dividend) | -$689M | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $11.5B | $7.9B | $3.3B | $3B | $3B | |
| Long-Term Debt Repaid | -$896M | -$3.5B | -$1.2B | -$7B | -$4.8B | |
| Repurchase of Common Stock | -- | -$94M | -$82M | -- | -- | |
| Other Financing Activities | -- | -$286M | -$1M | -$53M | -$40M | |
| Cash From Financing | $13.7B | $4.9B | $3.2B | -$4.2B | -$2B | |
| Beginning Cash (CF) | $8.8B | $26.7B | $22.5B | $16B | $6.4B | |
| Foreign Exchange Rate Adjustment | $63M | $13M | -$67M | $25M | $10M | |
| Additions / Reductions | $7.6B | -$2.4B | -$1.8B | -$3.2B | -$902M | |
| Ending Cash (CF) | $16.5B | $24.4B | $20.6B | $12.9B | $5.5B | |
| Levered Free Cash Flow | -$6.5B | -$6.9B | -$5.3B | $750M | $978M | |
Get CUK Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CUK
Sector
P/E ratio
17.50x
16.83x
PEG ratio
--
0.22x
P/B ratio
3.44x
1.45x
Price / LTM sales
1.30x
0.71x
Growth Metrics
CUK
Sector
Revenue growth
10.05%
0.14%
Earnings growth
--
--
Revenue (5-year growth)
3.74%
3.45%
Earnings forecast
--
$0.30
Profitability
CUK
Sector
Profitability FY 2024
$6.8B
$503.7M
Return on invested capital
5.17%
5.17%
Return on assets
3.87%
3.13%
Return on equity
25.06%
7.63%
Earnings Date
Last Earnings Date
Dec
20
Next Earnings Date
Mar
27
Estimated Next Earnings Date
Mar
21
Balance Sheet
CUK
Sector
Total cash
$1.2B
$157.7M
Short term investments
--
$60.7M
Total assets
$49.1B
$1.7B
Long term debt
$27.5B
$111.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
